Faes Farma and Pfizer Are Negotiating Semi Exclusive Licences for Bilastine in Certain Countries

BILBAO, Spain, June 22, 2009--Faes Farma is still in conversations with high level partners (Pfizer is the world leader) in order to complete the co-marketing agreements in Europe and in the big emergent markets.

Once the Registration Dossier has been submitted to the EMEA, our company´s efforts are concentrated in completing, during the next months, the negotiation processes opened in South America and Africa, and for second brands in the big European markets.

Faes Farma Group
Investor Relations Department
Tlf: 901 120 362
e-mail: accionistas@faes.es
web: www.faes.es

Posted: June 2009


View comments

Hide
(web4)